{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:19:06Z","timestamp":1791029946925,"version":"4.1.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"DOI":"10.1210\/jc.2008-1862","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T03:58:42Z","timestamp":1229486322000},"page":"861-868","source":"Crossref","is-referenced-by-count":86,"title":["Procalcitonin: A Marker for the Diagnosis and Follow-Up of Patients with Medullary Thyroid Carcinoma"],"prefix":"10.1210","volume":"94","author":[{"given":"Alicia","family":"Algeciras-Schimnich","sequence":"first","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology (A.A.-S., C.M.P., J.P.T., M.S.F., S.K.G.G.) Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Preissner","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology (A.A.-S., C.M.P., J.P.T., M.S.F., S.K.G.G.) Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Theobald","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology (A.A.-S., C.M.P., J.P.T., M.S.F., S.K.G.G.) Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Finseth","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology (A.A.-S., C.M.P., J.P.T., M.S.F., S.K.G.G.) Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K. G.","family":"Grebe","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Pathology (A.A.-S., C.M.P., J.P.T., M.S.F., S.K.G.G.) Mayo Clinic, Rochester, Minnesota 55905"},{"name":"Medicine (S.K.G.G.) Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113315529100_R1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1023\/A:1008242302749","article-title":"Current diagnosis and management of medullary thyroid carcinoma.","volume":"9","author":"Giuffrida","year":"1998","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t2019041113315529100_R2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","article-title":"Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times","volume":"158","author":"Laure Giraudet","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113315529100_R3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1210\/jcem-58-5-889","article-title":"Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.","volume":"58","author":"Saad","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113315529100_R4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2004.02037.x","article-title":"Medullary thyroid carcinoma.","volume":"61","author":"Leboulleux","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113315529100_R5","first-page":"15","article-title":"[Hypercalcitoninemia in conditions other than medullary cancers of the thyroid].","volume":"57","author":"Niccoli","year":"1996","journal-title":"Ann Endocrinol (Paris)"},{"key":"key\n\t\t\t\t2019041113315529100_R6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-002-6613-0","article-title":"Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.","volume":"26","author":"Iacobone","year":"2002","journal-title":"World J Surg"},{"key":"key\n\t\t\t\t2019041113315529100_R7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/1097-0142(197908)44:2<680::AID-CNCR2820440240>3.0.CO;2-J","article-title":"Calcitonin as a marker for bronchogenic cancer: a prospective study.","volume":"44","author":"Silva","year":"1979","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041113315529100_R8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10408369009105900","article-title":"The calcitonin gene peptides: biology and clinical relevance.","volume":"28","author":"Zaidi","year":"1990","journal-title":"Crit Rev Clin Lab Sci"},{"key":"key\n\t\t\t\t2019041113315529100_R9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/172460089400900104","article-title":"Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma.","volume":"9","author":"Fugazzola","year":"1994","journal-title":"Int J Biol Markers"},{"key":"key\n\t\t\t\t2019041113315529100_R10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/acta.0.0890089","article-title":"Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.","volume":"89","author":"Becker","year":"1978","journal-title":"Acta Endocrinol"},{"key":"key\n\t\t\t\t2019041113315529100_R11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI108956","article-title":"Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.","volume":"61","author":"Goltzman","year":"1978","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113315529100_R12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM198101293040505","article-title":"Calcitonin: physiology and pathophysiology.","volume":"304","author":"Austin","year":"1981","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113315529100_R13","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1007\/BF02900740","article-title":"The natural elimination rate of procalcitonin in patients with normal and impaired renal function","volume":"26","author":"Meisner","year":"2000","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019041113315529100_R14","first-page":"597","article-title":"Procalcitonin\u2014influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations.","volume":"35","author":"Meisner","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"key\n\t\t\t\t2019041113315529100_R15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/00313020701444564","article-title":"Procalcitonin for the clinical laboratory: a review.","volume":"39","author":"Schneider","year":"2007","journal-title":"Pathology"},{"key":"key\n\t\t\t\t2019041113315529100_R16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1089\/105072503768499716","article-title":"Calcitonin precursor levels in human medullary thyroid carcinoma.","volume":"13","author":"Bihan","year":"2003","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113315529100_R17","first-page":"6845","article-title":"Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.","volume":"49","author":"Ghillani","year":"1989","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t2019041113315529100_R18","volume-title":"Defining, establishing, and verifying reference intervals in the clinical laboratory, Approved Guideline, third edition","year":"2008"},{"key":"key\n\t\t\t\t2019041113315529100_R19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clinbiochem.2006.10.027","article-title":"Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis.","volume":"40","author":"Matzaraki","year":"2007","journal-title":"Clin Biochem"},{"key":"key\n\t\t\t\t2019041113315529100_R20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/030089160308900525","article-title":"Evaluation of circulating calcitonin: analytical aspects.","volume":"89","author":"Martinetti","year":"2003","journal-title":"Tumori"},{"key":"key\n\t\t\t\t2019041113315529100_R21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/3\/861\/9063398\/jcem0861.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T10:40:13Z","timestamp":1558003213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/3\/861\/2596499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-1862","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,1]]}}}